Hanna Schutz

Hanna completed her M.Eng. in Biological Chemistry from University of Applied Sciences in Mannheim, Germany and a PhD in Biochemistry and Molecular Biology from University of Vienna, Austria.

Hanna undertook her PhD work at the Research Institute of Molecular Pathology (IMP) in Vienna, investigating molecular mechanisms underlying human cell division, following a postdoctoral research position at the University of Oxford, where she worked on mitotic phosphatases.

In 2014 Hanna worked as a Business Analyst at PharmaVentures and moved on to further develop her Business Development capabilities at Cambridge Epigenetix Ltd., a biotech spin-out company from the University of Cambridge. Hanna has recently re-joined PharmaVentures as a Business Development Director, responsible for the company’s Marketing and Business Development activities in Europe and the US. 

Corporate-Advisory

Business Development Director

Mobile: 
+44 (0) 7951 205 428